Professional Documents
Culture Documents
Bio e Chival
Bio e Chival
SUMMARY
By pharmacokinetics investigating on 12 dogs of Romanian Sheperd breed, it was certified
the bioequivalance of two medicament formulas based on fenbendazole praziquantel and pyrantel,
the test product was represented by Anipratel ( produced by Animal Med ltd.) and the reference
product was represented by Cestal Plus. Using the ANOVA operating system permated the evaluation,
of the aditionaly secundary and primary pharmacokinetics parameters, requested by the KINETICA
program version 4.4.1 (Cmax , Tmax , AUCtot). With that, the products investigated hat diferent quantitys
of fenbendazole, (214,9 mg test formula and 200 mg reference formula), the tested
pharmacokinetics parameters had similar evolution. We also realized usualy statistics analyses
(average, standard deviation, standard error, minimum, maximum and the 95% trust range limits) and
for the finale apreciation we resort to quantification of the probability index, considereting the valus
biger then 0.05 and the absence of statistic diferences as necesary bioequivalance indicatores. To
notice that even if the test product had praziquantel in a larger quantity (51,1 mg) than the refernce
formula (50 mg), the probability index valuse obtenided from the comparation tests C max, Tmax i
AUCtot, did not revaled statistic diferences. In the same context it is explained also why the biger
quantity of pyrantel from the reference product (144 mg) did not influienced semnificatly two of the
tested parameters: Cmax (p=0,6970) i AUCtot (p=0,3664). The esambly of the obtenied data reveled the
bioequivalance of the product Antipratel tablets, the diferences beetwin the bioequivalance indicatores
were statisticaty insignificant (p>0,05).
studiu,
ncadrabil
n
domeniul
farmacocineticii,
investigm
biodisponibilitatea fenbendazolului, praziquantelului i pyrantelului,
substane active care compun un produs test supus bioechivalrii (Anipratel;
productor Animal-Med ltd) i unul referin (Cestal Plus).
MATERIAL I METOD
ANALIZA PROBELOR
CALCULE STATISTICE
celor dou formule analizate (tabel 2), iar variaia mediilor Tmax (de la
4,663,53 h pentru TEST la 4,873,37 h pentru REFERIN) nu a
relevant diferene importante n ceea ce privete limitele IC 95% (tabel 2).
Analiza valorilor AUCtot arat variaii largi ale acestui parametru n cazul
celor dou formule, cu toate acestea valoarea indicelui de probabilitate
(p=0,605) confirm c nu exist semnificaie statistic ntre nivelurile
nregistrate (tabel 2).
Tabel 2
Analiza comparativ a parametrilor farmacocinetici i statistici pentru dinamica
fenbendazolului
subiect
1
2
3
4
5
6
7
8
9
10
11
12
Medie
Dev.st
Er. st.
Minima
Maxima
L.inf.IC 95%
L.sup.IC 95%
valoare p
Cmax (ng/ml)
T
R
204,2
454,2
686,8
328,0
152,3
211,6
221,1
433,5
262,2
156,0
19,8
397,0
182,0
231,7
130
199,0
142,7
50,3
199,2
81,3
430,1
213,3
211,5
414,2
236,82
264,17
170,92
138,35
49,34
39,93
19,80
50,30
686,80
454,20
128,22
176,27
345,43
352,08
0,6710
Tmax (h)
T
R
1,5
4
8
4
2
1,5
12
2
4
1,5
0,5
12
4
8
2
8
2
1,5
8
4
4
8
8
4
4,66
4,87
3,53
3,37
1,01
0,97
0,50
1,50
12,00
12,00
2,42
2,72
6,91
7,02
0,8840
AUCtot(ng/ml*h)
T
R
986,5
2830,1
5109,0
2629,4
2967,9
4281,4
5333,7
2557,3
2431,0
795,7
120,2
6743,4
2201,9
2287,0
2753,0
4355,4
682,2
346,8
624,4
880,9
3437,0
2835,1
2849,5
3392,4
2458,02
2827,90
1677,90
1773,00
484,37
511,81
120,20
346,80
5333,7
6743,40
1391,90
1701,40
3524,10
3954,40
0,6051
T=test; R=referin
Tabel 3
Analiza comparativ a parametrilor farmacocinetici i statistici pentru dinamica
praziquantelului
Cmax (ng/ml)
subiect
1
2
3
4
5
6
7
8
9
10
11
12
Medie
Dev.st
Er. st.
Minima
Maxima
L.inf.IC 95%
L.sup.IC 95%
valoare p
Tmax (h)
R
657,7
636,3
403,0
201,8
872,0
570,6
1031,0
824,4
638,9
823,8
214,4
234,5
1227,2
541,3
789,5
623,0
597,8
454,2
228,6
240,5
614,3
734,6
718,5
609,4
666,07
541,20
298,66
218,67
86,21
63,12
214,40
201,80
1227,20
824,40
476,31
402,26
855,84
680,14
0,2563
0,5
0,5
1
4
1,5
0,5
2
2
0,5
1
1,5
8
1
4
1,5
1
1
1,5
4
4
2
2
4
2
1,70
2,54
1,17
2,15
0,33
0,62
0,50
0,50
4,00
8,00
0,96
1,17
2,45
3,91
0,2564
AUCtot(ng/ml*h)
T
R
1401,8
1776,3
1596,9
2249,0
4400,9
3985,5
7334,9
3886,9
2902,0
2374,9
877,5
3347,8
5994,9
9720,6
3683,0
4233,67
1581,2
1751,4
3913,9
1778,8
2884,6
5438,7
5388,0
2853,4
3496,63
3616,41
2018,80
2245,80
582,78
648,30
877,50
1751,40
7334,90
9720,60
2213,90
2189,50
4779,30
5043,30
0,8920
T=test; R=referin
Tabel 4
Analiza comparativ a parametrilor farmacocinetici i statistici
pentru dinamica pyrantelului
subiect
1
2
3
4
5
6
7
8
9
10
11
12
Medie
Dev.st
Er. st.
Minima
Maxima
L.inf.IC 95%
L.sup.IC 95%
valoare p
Cmax (ng/ml)
T
R
453,7
519,8
655,6
395,6
700,1
703,8
629,3
721,6
666,8
497,0
225,7
497,1
885,5
431,0
739,8
792,0
544,1
825,1
446,3
433,6
569,8
791,8
590,4
826,0
592,25
619,53
167,34
171,10
48,30
49,39
225,70
395,60
885,50
826,00
485,94
510,82
698,58
728,25
0,6970
T=test; R=referin
Tmax (h)
T
1,5
2
1,5
4
1
4
2
1,5
2
4
4
4
2,62
1,24
0,35
1,00
4,00
1,83
3,41
R
4
8
4
4
2
8
4
4
4
8
4
4
4,83
1,99
0,57
2,00
8,00
3,56
6,09
0,0044
AUCtot(ng/ml*h)
T
R
3233,5
3480,3
4837,7
4563,0
4857,9
8858,2
7004,0
5516,9
4643,2
2637,2
3675,8
6789,8
5776,0
7516,2
5354,5
9967,9
3242,1
6366,7
6832,1
4870,2
7086,2
5501,6
7231,5
5954,6
5314,54
6001,88
1488,80
2098,80
429,79
605,84
323,50
2637,20
7231,50
9967,90
4368,60
4668,40
6260,50
7335,40
0,3664